Originally Posted by
trader_jackson
I don't know of any other company on the NZX 50 that can be remotely compared to PEB, not even XRO. I therefore don't think it is apportiate to try and compare capital raising done by other, generally much older, companies to a speculative bio-tech stock like PEB.
I do however agree that PEB, especially at current market cap, will be kicked out of NZX 50, but in the case of PEB I don't think it will adversely affect the share price, due to the nature of the company vs other NZX 50 companies.
I would almost argue (like I have in my previous post) to get 2 in 3 shareholders to put money in such a speculative investment, or for First NZ to even fully underwrite it, is a vote of confidence in PEB's future.